- Home
- TTOO vs CRIS Comparison
TTOO vs CRIS Comparison
Compare TTOO & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- CRIS
- Stock Information
- Founded
- TTOO 2006
- CRIS 2000
- Country
- TTOO United States
- CRIS United States
- Employees
- TTOO N/A
- CRIS N/A
- Industry
- TTOO Medical/Dental Instruments
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTOO Health Care
- CRIS Health Care
- Exchange
- TTOO Nasdaq
- CRIS Nasdaq
- Market Cap
- TTOO 36.4M
- CRIS 31.7M
- IPO Year
- TTOO 2014
- CRIS 2000
- Fundamental
- Price
- TTOO $1.36
- CRIS $5.34
- Analyst Decision
- TTOO Hold
- CRIS Strong Buy
- Analyst Count
- TTOO 1
- CRIS 3
- Target Price
- TTOO $5.00
- CRIS $26.00
- AVG Volume (30 Days)
- TTOO 282.8K
- CRIS 28.2K
- Earning Date
- TTOO 11-13-2024
- CRIS 10-31-2024
- Dividend Yield
- TTOO N/A
- CRIS N/A
- EPS Growth
- TTOO N/A
- CRIS N/A
- EPS
- TTOO N/A
- CRIS N/A
- Revenue
- TTOO $7,164,000.00
- CRIS $10,161,000.00
- Revenue This Year
- TTOO $50.31
- CRIS N/A
- Revenue Next Year
- TTOO $117.92
- CRIS N/A
- P/E Ratio
- TTOO N/A
- CRIS N/A
- Revenue Growth
- TTOO N/A
- CRIS N/A
- 52 Week Low
- TTOO $1.36
- CRIS $3.80
- 52 Week High
- TTOO $8.38
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- TTOO 17.24
- CRIS 51.09
- Support Level
- TTOO $1.38
- CRIS $5.10
- Resistance Level
- TTOO $1.55
- CRIS $5.51
- Average True Range (ATR)
- TTOO 0.12
- CRIS 0.27
- MACD
- TTOO 0.02
- CRIS 0.03
- Stochastic Oscillator
- TTOO 0.00
- CRIS 65.52
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.